Profitability
Weight: 15%
D-
30
- 5yr Avg ROIC -28.4%
- Operating Margin Trend +1214.16 pp/yr
IPSC
Century Therapeutics, Inc.
AlphaQuality composite grade, weighted for high-growth software businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.
Grade overrides the 28.7 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -45.2%
- 5yr Share-Count CAGR 9.6%
Growth Quality
Weight: 35%
D+
40
- Revenue-Growth Years (5) 2/5
Cash Generation
Weight: 20%
F
0
- 5yr FCF Margin -1663.9%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 10%
B+
75
- Net Debt / EBITDA -21.30x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score -2.41
Stability
Weight: 5%
C
54
- Negative-Revenue Years (5) 1/5
- Piotroski F-Score 3
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.Not enough curated-guru data to call a flow.
- Wood sold -100%